221 related articles for article (PubMed ID: 23824517)
1. A lack of premature termination codon read-through efficacy of PTC124 (Ataluren) in a diverse array of reporter assays.
McElroy SP; Nomura T; Torrie LS; Warbrick E; Gartner U; Wood G; McLean WH
PLoS Biol; 2013; 11(6):e1001593. PubMed ID: 23824517
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression.
Auld DS; Thorne N; Maguire WF; Inglese J
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3585-90. PubMed ID: 19208811
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124.
Auld DS; Lovell S; Thorne N; Lea WA; Maloney DJ; Shen M; Rai G; Battaile KP; Thomas CJ; Simeonov A; Hanzlik RP; Inglese J
Proc Natl Acad Sci U S A; 2010 Mar; 107(11):4878-83. PubMed ID: 20194791
[TBL] [Abstract][Full Text] [Related]
4. Toward a rationale for the PTC124 (Ataluren) promoted readthrough of premature stop codons: a computational approach and GFP-reporter cell-based assay.
Lentini L; Melfi R; Di Leonardo A; Spinello A; Barone G; Pace A; Palumbo Piccionello A; Pibiri I
Mol Pharm; 2014 Mar; 11(3):653-64. PubMed ID: 24483936
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of premature stop codon readthrough in the CFTR gene by Ataluren (PTC124) derivatives.
Pibiri I; Lentini L; Melfi R; Gallucci G; Pace A; Spinello A; Barone G; Di Leonardo A
Eur J Med Chem; 2015 Aug; 101():236-44. PubMed ID: 26142488
[TBL] [Abstract][Full Text] [Related]
6. Aminoglycosides, but not PTC124 (Ataluren), rescue nonsense mutations in the leptin receptor and in luciferase reporter genes.
Bolze F; Mocek S; Zimmermann A; Klingenspor M
Sci Rep; 2017 Apr; 7(1):1020. PubMed ID: 28432296
[TBL] [Abstract][Full Text] [Related]
7. Stop codon read-through with PTC124 induces palmitoyl-protein thioesterase-1 activity, reduces thioester load and suppresses apoptosis in cultured cells from INCL patients.
Sarkar C; Zhang Z; Mukherjee AB
Mol Genet Metab; 2011 Nov; 104(3):338-45. PubMed ID: 21704547
[TBL] [Abstract][Full Text] [Related]
8. Exploring the readthrough of nonsense mutations by non-acidic Ataluren analogues selected by ligand-based virtual screening.
Pibiri I; Lentini L; Tutone M; Melfi R; Pace A; Di Leonardo A
Eur J Med Chem; 2016 Oct; 122():429-435. PubMed ID: 27404557
[TBL] [Abstract][Full Text] [Related]
9. In vitro read-through of phenylalanine hydroxylase (PAH) nonsense mutations using aminoglycosides: a potential therapy for phenylketonuria.
Ho G; Reichardt J; Christodoulou J
J Inherit Metab Dis; 2013 Nov; 36(6):955-9. PubMed ID: 23532445
[TBL] [Abstract][Full Text] [Related]
10. Ataluren and aminoglycosides stimulate read-through of nonsense codons by orthogonal mechanisms.
Ng MY; Li H; Ghelfi MD; Goldman YE; Cooperman BS
Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33414181
[TBL] [Abstract][Full Text] [Related]
11. Translational Read-Through Therapy of
Vössing C; Owczarek-Lipska M; Nagel-Wolfrum K; Reiff C; Jüschke C; Neidhardt J
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182541
[TBL] [Abstract][Full Text] [Related]
12. Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis.
Sermet-Gaudelus I; Boeck KD; Casimir GJ; Vermeulen F; Leal T; Mogenet A; Roussel D; Fritsch J; Hanssens L; Hirawat S; Miller NL; Constantine S; Reha A; Ajayi T; Elfring GL; Miller LL
Am J Respir Crit Care Med; 2010 Nov; 182(10):1262-72. PubMed ID: 20622033
[TBL] [Abstract][Full Text] [Related]
13. Use of PTC124 for nonsense suppression therapy targeting BMP4 nonsense variants in vitro and the bmp4st72 allele in zebrafish.
Krall M; Htun S; Slavotinek A
PLoS One; 2019; 14(4):e0212121. PubMed ID: 31017898
[TBL] [Abstract][Full Text] [Related]
14. PTC124 targets genetic disorders caused by nonsense mutations.
Welch EM; Barton ER; Zhuo J; Tomizawa Y; Friesen WJ; Trifillis P; Paushkin S; Patel M; Trotta CR; Hwang S; Wilde RG; Karp G; Takasugi J; Chen G; Jones S; Ren H; Moon YC; Corson D; Turpoff AA; Campbell JA; Conn MM; Khan A; Almstead NG; Hedrick J; Mollin A; Risher N; Weetall M; Yeh S; Branstrom AA; Colacino JM; Babiak J; Ju WD; Hirawat S; Northcutt VJ; Miller LL; Spatrick P; He F; Kawana M; Feng H; Jacobson A; Peltz SW; Sweeney HL
Nature; 2007 May; 447(7140):87-91. PubMed ID: 17450125
[TBL] [Abstract][Full Text] [Related]
15. Comparison of read-through effects of aminoglycosides and PTC124 on rescuing nonsense mutations of HERG gene associated with long QT syndrome.
Yu H; Liu X; Huang J; Zhang Y; Hu R; Pu J
Int J Mol Med; 2014 Mar; 33(3):729-35. PubMed ID: 24366185
[TBL] [Abstract][Full Text] [Related]
16. PTC124-mediated translational readthrough of a nonsense mutation causing Usher syndrome type 1C.
Goldmann T; Overlack N; Wolfrum U; Nagel-Wolfrum K
Hum Gene Ther; 2011 May; 22(5):537-47. PubMed ID: 21235327
[TBL] [Abstract][Full Text] [Related]
17. Effect of Ataluren on dystrophin mutations.
Berger J; Li M; Berger S; Meilak M; Rientjes J; Currie PD
J Cell Mol Med; 2020 Jun; 24(12):6680-6689. PubMed ID: 32343037
[TBL] [Abstract][Full Text] [Related]
18. Limited premature termination codon suppression by read-through agents in cystic fibrosis intestinal organoids.
Zomer-van Ommen DD; Vijftigschild LA; Kruisselbrink E; Vonk AM; Dekkers JF; Janssens HM; de Winter-de Groot KM; van der Ent CK; Beekman JM
J Cyst Fibros; 2016 Mar; 15(2):158-62. PubMed ID: 26255232
[TBL] [Abstract][Full Text] [Related]
19. Treatment of a methylmalonyl-CoA mutase stopcodon mutation.
Buck NE; Wood LR; Hamilton NJ; Bennett MJ; Peters HL
Biochem Biophys Res Commun; 2012 Nov; 427(4):753-7. PubMed ID: 23041189
[TBL] [Abstract][Full Text] [Related]
20. PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model.
Du M; Liu X; Welch EM; Hirawat S; Peltz SW; Bedwell DM
Proc Natl Acad Sci U S A; 2008 Feb; 105(6):2064-9. PubMed ID: 18272502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
